ABBV
Another check from the cash machine
AbbVie’s board just declared a quarterly cash dividend of $1.73 per share. Translation: the company is still doing the classic mature-pharma thing — turning drug sales into shareholder paydays.
Why you should care
This isn’t a flashy pipeline headline or a giant M&A splash, but it does matter if you own the stock for income. Dividend declarations signal that management is comfortable enough with cash flow to keep the payout flowing, which is exactly the sort of thing income investors like to see when the market is acting like a caffeinated squirrel.
The big picture
AbbVie has spent years building a reputation as a dividend-friendly stock, and this move keeps that story intact. If you’re looking for explosive drama, keep walking. If you’re looking for a company that keeps writing checks, ABBV just stayed on script.
Big picture: boring can be beautiful when the dividend keeps landing on time.